FindTrial
Sign In

Asian population aging Atlas and age related pancreatic cancer and other disease susceptibility

Asian population aging Atlas and age related pancreatic cancer and other disease susceptibility

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127076
Enrollment
Unknown
Registered
2026-06-24
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

Control group:None
Case group:None

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Based on the sample database of Ruijin Hospital,Case group (300 cases): Patients clinically diagnosed with pancreatic cancer, irrespective of gender, age, or lesion location, and regardless of whether they have received chemotherapy, were included. Control group (300 cases): Individuals without evidence of pancreatic lesions, irrespective of gender and age, and including those who may have undergone other forms of treatment, were enrolled.

Exclusion criteria

Exclusion criteria: 1.None;

Design outcomes

Primary

MeasureTime frame
Genomics;Proteomics;Metabolomics;Transcriptomics;Lipomics;—

Countries

China

Contacts

Public ContactDa Fu

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

fuda@shsmu.edu.cn+86 21 34186000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026